Tepezza Lawsuits: Patients Seek Justice for Permanent Hearing Loss
In the realm of rare disease treatments, Tepezza (teprotumumab-trbw) emerged as a significant development for patients suffering from thyroid eye disease (TED). Developed by Horizon Therapeutics and approved by the FDA in January 2020, Tepezza became the first and only medication specifically designed to treat this uncommon autoimmune condition that can cause bulging eyes, double […]